A Prospective, Multicenter, Long-Term Study To Assess The Safety And Efficacy Of Nemolizumab (Cd14152) In Subjects With Moderate-To-Severe Atopic Dermatitis
Posted Date: Nov 5, 2024
- Investigator: Alan Fleischer
- Specialties:
- Type of Study: Drug
The purpose of the study is to to assess the long-term safety and efficacy of nemolizumab (CD14152) in adult and adolescent subjects with moderate-to-severe atopic dermatitis (AD).
Criteria:
Null
Keywords:
Atopic Dermatitis, Eczema
For More Information:
Jordan Sambrookes
NULL
perryj8@ucmail.uc.edu